Diffuse Large B-Cell Lymphoma (DLBCL) Updates

Listen Now

Topics Covered

• Overview of Diffuse Large B-Cell Lymphoma, in the Context of COVID-19, Delta & Omicron
• Staging & Grading
• Current Standard of Care
• Treatment Options for Resistant Disease
• Emerging Treatment Approaches
• The Role of Clinical Trials
• How Research Contributes to Treatment Choices
• Tips to Manage Side Effects, Symptoms, Discomfort & Pain
• The Increasing Role of Telehealth/Telemedicine Appointments
• Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
• Questions for Our Panel of Experts

Our Panel of Experts

Catherine S M Diefenbach, MD

Associate Professor of Medicine, Translational Director of Hematology/Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-designated Comprehensive Cancer Center, NYU Langone Health

Adolfo Enrique Diaz, MD, MSc

Assistant Professor, Department of Medicine, Division of Hematology-Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on March 02, 2022.